文献速递肝病

代谢功能障碍相关脂肪性肝病与新发心血管疾病风险:全国性队列研究

Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-12-22

该研究基于韩国全国健康筛查数据库,纳入2009至2010年间9,584,399名40-64岁参与者,比较NAFLD与MAFLD定义下脂肪肝患病率及心血管疾病风险。结果显示NAFLD与MAFLD患病率分别为28.0%和37.3%,MAFLD-only组心血管事件风险显著高于NAFLD-only组,提示MAFLD标准可识别更多代谢复杂且心血管风险升高的脂肪肝个体。

要点

  • MAFLD患病率(37.3%)高于NAFLD(28.0%),MAFLD标准可识别更多脂肪肝患者。
  • MAFLD-only组心血管事件风险(HR 1.43)显著高于NAFLD-only组(HR 1.09)。
  • MAFLD标准较NAFLD更能识别代谢复杂且心血管风险升高的脂肪肝个体。

核心结论

  • 相当比例的中年韩国成人存在MAFLD但不满足旧版NAFLD定义,从NAFLD改为MAFLD标准可识别更多代谢复杂且心血管风险升高的脂肪肝个体。

研究设计与样本

  • 基于韩国全国健康筛查数据库的全国性队列研究,纳入2009至2010年间9,584,399名40-64岁参与者(男性48.5%),中位随访10.1年。

主要发现

  • NAFLD和MAFLD患病率分别为28.0%和37.3%。
  • 以Neither-FLD组为参照,多变量调整后心血管事件风险比(95%CI)在NAFLD-only组为1.09(1.03-1.15),MAFLD-only组为1.43(1.41-1.45),Both-FLD组为1.56(1.54-1.58)。

临床怎么用

  • 采用MAFLD标准评估脂肪肝可识别更多心血管风险升高的个体,有助于强化心血管风险评估与预防。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: An international expert panel proposed a new definition for metabolic dysfunction-associated fatty liver disease (MAFLD) as a name change from nonalcoholic fatty liver disease (NAFLD). The clinical impact of this change on the assessment of cardiovascular disease (CVD) risk is yet unknown. We evaluated the prevalence of fatty liver disease (FLD) and the associated CVD risk using each of these definitions. METHODS: From a nationwide health screening database, we included 9,584,399 participants (48.5% male) aged 40-64 years between 2009 and 2010. Participants were categorized by presence of NAFLD and MAFLD, separately, and by the combination of the 2 definitions-Neither-FLD, NAFLD-only, MAFLD-only, or Both-FLD. The primary outcome was a composite CVD event, including myocardial infarction, ischemic stroke, heart failure, or CVD-related death. RESULTS: The prevalence of NAFLD and MAFLD was 28.0% and 37.3%, respectively. After excluding those with prior CVD, 8,962,813 participants were followed for a median of 10.1 years. NAFLD and MAFLD were each associated with significantly higher risk for CVD events. When the Neither-FLD group was the reference, multivariable-adjusted hazard ratios (95% confidence interval) for CVD events were 1.09 (1.03-1.15) in the NAFLD-only group, 1.43 (1.41-1.45) in the MAFLD-only group, and 1.56 (1.54-1.58) in the Both-FLD group. CONCLUSIONS: A considerable proportion of middle-aged Korean adults have MAFLD without satisfying the former definition of NAFLD. The change from NAFLD to MAFLD criteria may identify a greater number of individuals with metabolically complicated fatty liver and increased risk for CVD.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Lee H, Lee YH, Kim SU, et al. Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study. Clin Gastroenterol Hepatol. 2020. PMID: 33348045. doi:10.1016/j.cgh.2020.12.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。